Nerve Injury in the Prosthetic Management of the Dysplastic Hip-Reference-Cited by-同舟云学术

Nerve Injury in the Prosthetic Management of the Dysplastic Hip

Published:1998-09 Issue:9 Volume:21 Page:980-981
ISSN:0147-7447
Container-title:Orthopedics
language:en
Short-container-title:Orthopedics

Author:

Cameron Hugh U,Eren O T,Solomon M

Publisher

SLACK, Inc.

Subject

Orthopedics and Sports Medicine,Surgery

Reference7 articles.

1. 1. Crowe JF Massi JV Ranawat CS. Total hip replacement in congenital dislocation and dysplasia of the hip. J Bone Joint Surg Am. 1979; 61:15-23.

2. 2. Cameron HU. Botsford DJ Park Y-S. Influence of Crowe rating on die outcome of total hip arthroplasty in CDH. J Arthroplasty. 1996; 11:582-587.

3. 3. Edward BN Tullos HS Noble PC. Contributory factors and etiology of sciatic nerve palsy in total hip arthroplasty. Clin Orthop. 1987; 218:136-141.

4. 4. Nercessian OA Macaulay W Stinchfield FE. Peripheral neuropathy following total hip arthroplasty. J Arthroplasty. 1994;6:645-665.

5. 5. Nercessian OA Piccoluga F Eftekhar NS. Post-operative sciatica in femoral nerve palsy with reference to leg lengthening and medialization/lateralization of the hip joint following total hip arthroplasty. Clin Orthop. 1994; 304:165-171.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Staged Bilateral Total Hip Arthroplasty in a Patient With Short Stature and Hartofilakidis Type I Developmental Dysplasia of the Hip;Cureus;2024-01-22

2. Current Surgical Techniques in the Treatment of Adult Developmental Dysplasia of the Hip;Journal of Personalized Medicine;2023-06-01

3. Sciatic Nerve Palsy After Total Hip Arthroplasty;JBJS Journal of Orthopaedics for Physician Assistants;2023

4. Anatomical Parameters Associated with the Shortening Decision in Crowe Type 4 Dysplastic Hip Osteoarthritis: A Case–Control Study;Indian Journal of Orthopaedics;2022-08-10

5. The Course and Anatomical Characteristics of Sciatic and Femoral Nerves in Unilateral Crowe Type-IV Hip Dysplasia;Therapeutics and Clinical Risk Management;2022-04